Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin thera...
Saved in:
| Main Authors: | Barbara Steinlechner, Gabriele Kargl, Christine Schlömmer, Caroline Holaubek, Georg Scheriau, Sabine Eichinger, Johannes Gratz, Bernhard Rössler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Immunology |
| Online Access: | http://dx.doi.org/10.1155/2021/6624682 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia
by: Caroline Holaubek, et al.
Published: (2020-01-01) -
Pseudothrombocytopenia Inducing Nonindicated Platelet Transfusion after Cardiac Surgery
by: Enise Ceran, et al.
Published: (2021-01-01) -
Prevalence and impact of ECMO cannula colonization: a single center study
by: Klaus-Georg Kreitmeier, et al.
Published: (2025-05-01) -
Modern Approach to the Treatment of Acute Respiratory Failure – from nasal cannula to ECMO
by: Szymon Gruszka, et al.
Published: (2025-04-01) -
Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia
by: Ryo Kanamoto, et al.
Published: (2020-01-01)